USPTO serial 85857854
VELA
Reviewed by CopyMark Law Group
Reg. 4848776Status 710
- Filing date
- Status date
- Registration date
- Nov 10, 2015
- Examiner
- WILSON, MARYNELLE WEST
- Law office
- TMO LAW OFFICE 113
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VELA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
VELA DIAGNOSTICS HOLDING PTE. LTD.
SCIENCE PARK II, SG
Other trademarks owned by VELA DIAGNOSTICS HOLDING PTE. LTD.
VELA DIAGNOSTICS HOLDING PTE. LTD.
SCIENCE PARK II, SG
Other trademarks owned by VELA DIAGNOSTICS HOLDING PTE. LTD.
Singapore 117406, SG
Singapore 117406, SG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stacy L. Emhoff
Stacy L. Emhoff Walker & Jocke Co., LPA231 South BroadwayMEDINA, OH 44256-2601UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological and chemical substances used in industry and for scientific and research purposes, namely, diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents for research and not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, synthesis, amplification, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid assays and chemical reagents for research, except for human medicine and veterinary medicine purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; biological substances and chemicals used for medical scientific and medical research purposes, namely, reagents and solvents for research, in particular for sample preparation, modification and manipulation of cells as well as for the performance of synthesis, amplification, labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of protein assays and chemical reagents for medical scientific and medical research purposes, in particular for sample preparation, modification and manipulation of cells as well as for synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules | SECTION 8 - CANCELLED | Feb 18, 2013 |
| 005 | In-vitro diagnostic preparations for medical purposes; sanitary preparations for medical purposes | SECTION 8 - CANCELLED | Feb 18, 2013 |
| 009 | Scientific apparatus and instruments for laboratory use, in particular for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances; scientific apparatus and instruments for scientific research, non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances; computer hardware; computer software for operation and maintenance of scientific apparatus, instruments and equipment, namely, for electrophoretic apparatuses, homogenizers, spectrophotometers and laboratory robots; computer software for creating experimental profiles and providing experimental reports based on sample preparation, modification and manipulation of cells as well as on synthesis, amplification, labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules; computer software for creating reports of apparatus performance verification, namely, for apparatuses for research and development purposes in the nature of thermocyclers for amplifying, and analyzing biopolymers, in particular nucleic acids and biologically active substances, and for apparatuses for non-medical diagnostic analysis, chemical analysis, clinical analysis, namely, electrophoretic apparatuses, homogenizers for marking, separating, isolating, purifying, amplifying, and analyzing biopolymers, in particular nucleic acids, proteins macro molecules and biologically active substances; computer software for analyzing, displaying and visualizing experimental data and biological data, namely, polymerase chain reaction data, Real-Time-polymerase chain reaction data, and electrophoresis data | SECTION 18 - CANCELLED | Feb 18, 2013 |
| 010 | Medical apparatus and implements, namely, apparatus and implements for the conducting and evaluation of clinical diagnostic examinations for medical purposes, with none being apparatus or instruments for in cosmetic or aesthetic practice or procedures, or any products that involve respiratory testing, respiratory diagnostics or blood gas analyzers with the exception of products for the molecular diagnosis of pathogenic microorganisms, such as bacteria and viruses that may infect the respiratory tract | SECTION 8 - CANCELLED | Feb 18, 2013 |
| 042 | Scientific and technological services, namely, scientific research services and scientific consultancy services in the field of scientific research, analysis and testing in the field of clinical, veterinary, environmental and medical diagnosis; development of computer hardware and software none being apparatus or instruments for use in cosmetic or aesthetic practice or procedures for the operation and maintenance of scientific apparatus, instruments and equipment; development of computer software for creating experimental profiles, providing experimental reports and reports of apparatus performance verification; development of computer software for analyzing, displaying and visualizing experimental data and biological data, none of the services involve respiratory testing, respiratory diagnostics or blood gas analyzers with the exception of services for the molecular diagnosis of pathogenic microorganism, such as bacteria and viruses that my infect the respiratory tract | SECTION 18 - CANCELLED | Feb 18, 2013 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by VELA DIAGNOSTICS HOLDING PTE. LTD.
- Other trademarks owned by VELA DIAGNOSTICS HOLDING PTE. LTD.
- Other trademarks owned by Vela Holding Pte. Ltd.
- Other trademarks owned by Vela Holding Pte. Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named VELA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 22, 2026 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Nov 10, 2024 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Oct 22, 2024 | C18P | CANCELLED SECTION 18-PARTIAL | — |
| Oct 22, 2024 | TTCG | BOARD DECISION: COUNTERCLAIM GRANTED | — |
| Nov 2, 2023 | CCON | COUNTERCLAIM OPP. NO. 999999 | — |
| Nov 2, 2021 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 2, 2021 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 2, 2021 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 27, 2021 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 10, 2020 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 10, 2015 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 20, 2015 | AOUM | ASSIGNMENT OF OWNERSHIP UPDATED MANUALLY | — |
| Oct 1, 2015 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Oct 1, 2015 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Oct 1, 2015 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Sep 23, 2015 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Aug 24, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 29, 2015 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Apr 8, 2015 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 17, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 17, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 25, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 12, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 11, 2015 | ALIE | ASSIGNED TO LIE | — |
| Feb 6, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 6, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 6, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 6, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 5, 2015 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 3, 2015 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 20, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 20, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 20, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 20, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 20, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 20, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 30, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 29, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 29, 2014 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 6, 2014 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 6, 2014 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 6, 2014 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Oct 1, 2014 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Sep 16, 2014 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 4, 2014 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 4, 2014 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2014 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 26, 2014 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2014 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2014 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 16, 2014 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2014 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2014 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 25, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 24, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 24, 2014 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 5, 2014 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2014 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 5, 2014 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 15, 2014 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 14, 2014 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 14, 2014 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Jan 7, 2014 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 7, 2014 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 7, 2014 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 3, 2014 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Dec 27, 2013 | ALIE | ASSIGNED TO LIE | — |
| Jun 7, 2013 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 7, 2013 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 7, 2013 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 6, 2013 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2013 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2013 | NWAP | NEW APPLICATION ENTERED | — |